El Salvador vs Senegal: The number of people with susceptibility test result for rifampicin
El Salvador
26.6
in 2021
Senegal
30.79
in 2021
El Salvador rank
135th
Senegal rank
132nd
The number of people with susceptibility test result for rifampicin over time
- El Salvador
- Senegal
How they compare
Senegal currently reports 30.79 against 26.6 in El Salvador, a difference of 4.19.
That makes Senegal's figure about 1.2 times El Salvador's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Senegal ahead.
El Salvador ranks 135th and Senegal ranks 132nd of 146 countries.
El Salvador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | El Salvador | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 34.13 | 24.99 | 9.14 | El Salvador |
| 2020s | 33.06 | 23.63 | 9.43 | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, El Salvador or Senegal?
- Senegal, at 30.79 against 26.6 in El Salvador as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between El Salvador and Senegal?
- 4.19, with Senegal ahead.
- How many years of comparable data are there for El Salvador and Senegal?
- 5 years are reported by both, from 2017 to 2021.
- How do El Salvador and Senegal rank globally for the number of people with susceptibility test result for rifampicin?
- El Salvador ranks 135th and Senegal ranks 132nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.